Go Pro

LeMaitre Vascular (LMAT) 10K Form and Latest SEC Filings 2026

LeMaitre Vascular logo
$98.10 -2.20 (-2.19%)
As of 10:23 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest LeMaitre Vascular SEC Filings & Recent Activity

LeMaitre Vascular (NASDAQ:LMAT) has submitted 658+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in LeMaitre Vascular's financial statements. The most recent filing was a Form 4 submitted on June 5, 2026.

Form 4
LEMAITRE VASCULAR INC Reports Ownership Change on Jun. 5, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

10-Q
LeMaitre Vascular Files Quarterly Report on May. 6, 2026

The 10-Q contains LeMaitre Vascular's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

LeMaitre Vascular SEC Filing History

Browse LeMaitre Vascular's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
06/05/2026 4:37 PM
LeMaitre Vascular (1158895) Issuer
O'Connor John James (1382475) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2026 4:38 PM
Jasinski Lawrence J (1366346) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2026 4:29 PM
LeMaitre George W (1365737) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2026 4:30 PM
Kamke Trent G (1365739) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2026 4:31 PM
LeMaitre Vascular (1158895) Issuer
Roberts David B (1365731) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2026 4:33 PM
LeBlanc Dorian Paul (2061481) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2026 4:34 PM
LeMaitre Vascular (1158895) Issuer
Pellegrino Joseph P JR (1365733) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2026 4:35 PM
LeMaitre Vascular (1158895) Issuer
SHADAN MARTHA (1871700) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2026 4:36 PM
LeMaitre Vascular (1158895) Issuer
Roush John A (1308225) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2026 7:47 AM
LeMaitre Vascular (1158895) Filer
Form SD
Specialized Disclosure Report  
05/14/2026 7:59 AM
LeMaitre George W (1365737) Filed by
LeMaitre Vascular (1158895) Subject
Form SCHEDULE 13G/A
05/11/2026 5:22 PM
LeMaitre George W (1365737) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2026 4:08 PM
Jasinski Lawrence J (1366346) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2026 4:10 PM
LeMaitre Vascular (1158895) Issuer
Ross Bridget A (1698518) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2026 4:13 PM
Kamke Trent G (1365739) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2026 3:21 PM
Kamke Trent G (1365739) Reporting
LeMaitre Vascular (1158895) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2026 3:04 PM
Jasinski Lawrence J (1366346) Reporting
LeMaitre Vascular (1158895) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2026 5:30 AM
LeMaitre Vascular (1158895) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2026 3:34 PM
LeMaitre Vascular (1158895) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2026 6:53 PM
LeMaitre Vascular (1158895) Issuer
Pellegrino Joseph P JR (1365733) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2026 6:33 AM
LeMaitre Vascular (1158895) Filer
Form DEF 14A
04/14/2026 6:36 AM
LeMaitre Vascular (1158895) Filer
Form DEFA14A
04/14/2026 5:45 AM
LeMaitre Vascular (1158895) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2026 5:30 AM
LeMaitre Vascular (1158895) Filer
Form ARS
03/30/2026 4:58 PM
Jasinski Lawrence J (1366346) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 5:00 PM
LeMaitre Vascular (1158895) Issuer
Roush John A (1308225) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 5:02 PM
LeMaitre Vascular (1158895) Issuer
O'Connor John James (1382475) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 5:03 PM
LeMaitre Vascular (1158895) Issuer
Ross Bridget A (1698518) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 5:10 PM
LeMaitre Vascular (1158895) Issuer
SHADAN MARTHA (1871700) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 4:34 PM
LeMaitre George W (1365737) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2026 9:21 AM
LeMaitre Vascular (1158895) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/13/2026 3:42 PM
LeMaitre Vascular (1158895) Issuer
Roberts David B (1365731) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 3:42 PM
Kamke Trent G (1365739) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2026 3:03 PM
Kamke Trent G (1365739) Reporting
LeMaitre Vascular (1158895) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2026 10:28 AM
LeMaitre Vascular (1158895) Subject
Roberts David B (1365731) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/02/2026 8:16 PM
LeMaitre Vascular (1158895) Issuer
SHADAN MARTHA (1871700) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 8:13 PM
LeMaitre Vascular (1158895) Issuer
Roush John A (1308225) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 7:57 PM
LeMaitre Vascular (1158895) Issuer
Roberts David B (1365731) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 8:01 PM
Kamke Trent G (1365739) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 8:06 PM
LeMaitre Vascular (1158895) Issuer
Pellegrino Joseph P JR (1365733) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 8:08 PM
Jasinski Lawrence J (1366346) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
Confirm Your Name Before the Letter Goes Out (Ad)

Americans who believe in real retirement protection are adding their names to a statement going out to Washington and Wall Street. It's a message that people are fed up with inflation and the erosion of their savings. President Trump took a stand on protecting American wealth. Now you can add your voice while also learning how to move part of your IRA or 401(k) into physical gold and silver, tax and penalty free.tc pixel

Add your name and claim your free Gold IRA Guide today.
03/02/2026 8:10 PM
LeMaitre Vascular (1158895) Issuer
O'Connor John James (1382475) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 8:12 PM
LeMaitre Vascular (1158895) Issuer
Ross Bridget A (1698518) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 7:44 PM
LeMaitre George W (1365737) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 11:06 AM
LeMaitre George W (1365737) Reporting
LeMaitre Vascular (1158895) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2026 10:48 AM
LeMaitre Vascular (1158895) Subject
Roberts David B (1365731) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 2:57 PM
LeMaitre George W (1365737) Reporting
LeMaitre Vascular (1158895) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 9:10 AM
LeMaitre George W (1365737) Reporting
LeMaitre Vascular (1158895) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 6:01 AM
LeMaitre Vascular (1158895) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/06/2026 3:48 PM
LeMaitre Vascular (1158895) Issuer
Roberts David B (1365731) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2026 4:16 PM
Kamke Trent G (1365739) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2026 8:22 AM
Conestoga Capital Advisors, LLC (1163744) Filed by
LeMaitre Vascular (1158895) Subject
Form SCHEDULE 13G/A
12/15/2025 5:14 PM
LeMaitre George W (1365737) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2025 5:12 PM
LeMaitre Vascular (1158895) Issuer
Pellegrino Joseph P JR (1365733) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2025 5:12 PM
Kamke Trent G (1365739) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2025 5:13 PM
LeMaitre Vascular (1158895) Issuer
Roberts David B (1365731) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2025 5:07 PM
LeMaitre Vascular (1158895) Issuer
Roush John A (1308225) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2025 5:09 PM
Jasinski Lawrence J (1366346) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2025 5:10 PM
LeMaitre Vascular (1158895) Issuer
O'Connor John James (1382475) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2025 5:10 PM
LeMaitre Vascular (1158895) Issuer
Ross Bridget A (1698518) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2025 5:11 PM
LeMaitre Vascular (1158895) Issuer
SHADAN MARTHA (1871700) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2025 5:07 PM
LeMaitre Vascular (1158895) Issuer
Roush John A (1308225) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2025 5:07 PM
LeMaitre Vascular (1158895) Issuer
SHADAN MARTHA (1871700) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2025 5:08 PM
LeMaitre Vascular (1158895) Issuer
Ross Bridget A (1698518) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2025 5:08 PM
LeMaitre Vascular (1158895) Issuer
O'Connor John James (1382475) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2025 5:09 PM
Jasinski Lawrence J (1366346) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2025 5:09 PM
LeMaitre Vascular (1158895) Issuer
Pellegrino Joseph P JR (1365733) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2025 5:09 PM
LeMaitre Vascular (1158895) Issuer
Roberts David B (1365731) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2025 5:10 PM
LeBlanc Dorian Paul (2061481) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2025 5:10 PM
LeMaitre George W (1365737) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2025 5:10 PM
Kamke Trent G (1365739) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 6:26 PM
LeMaitre Vascular (1158895) Issuer
SHADAN MARTHA (1871700) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 6:26 PM
LeMaitre Vascular (1158895) Issuer
Roush John A (1308225) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 6:26 PM
LeMaitre Vascular (1158895) Issuer
Ross Bridget A (1698518) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 6:26 PM
LeMaitre Vascular (1158895) Issuer
O'Connor John James (1382475) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 6:27 PM
Jasinski Lawrence J (1366346) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 6:27 PM
LeMaitre Vascular (1158895) Issuer
Pellegrino Joseph P JR (1365733) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 6:27 PM
Kamke Trent G (1365739) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 6:27 PM
LeMaitre Vascular (1158895) Issuer
Roberts David B (1365731) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 6:28 PM
LeMaitre George W (1365737) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2025 7:31 PM
LeBlanc Dorian Paul (2061481) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2025 7:32 PM
LeMaitre Vascular (1158895) Issuer
Roberts David B (1365731) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2025 7:33 PM
Kamke Trent G (1365739) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2025 7:18 PM
LeMaitre George W (1365737) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2025 7:19 PM
LeMaitre Vascular (1158895) Issuer
SHADAN MARTHA (1871700) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2025 7:20 PM
LeMaitre Vascular (1158895) Issuer
Ross Bridget A (1698518) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2025 7:20 PM
LeMaitre Vascular (1158895) Issuer
Roush John A (1308225) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2025 7:21 PM
Jasinski Lawrence J (1366346) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2025 7:22 PM
LeMaitre Vascular (1158895) Issuer
O'Connor John James (1382475) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2025 7:25 PM
LeMaitre Vascular (1158895) Issuer
Pellegrino Joseph P JR (1365733) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 6:38 PM
LeMaitre Vascular (1158895) Issuer
Roberts David B (1365731) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
They told you not to miss this one (Ad)

The largest companies in the SP 500 are now more overvalued relative to fundamentals than they were at the absolute peak of the dot-com era. An MIT study found that 95% of companies investing in AI are seeing zero measurable return - yet the spending continues. OpenAI CEO Sam Altman has publicly said investors are 'overexcited' about AI. The investors who survived the dot-com crash weren't the ones who called the bottom - they were the ones who weren't fully exposed when it happened. Thor Metals Group offers a free guide on building a retirement not tied to this bet.tc pixel

Get your free guide from Thor Metals Group and protect your retirement
12/03/2025 6:39 PM
LeMaitre George W (1365737) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 6:39 PM
LeMaitre Vascular (1158895) Issuer
Pellegrino Joseph P JR (1365733) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 6:41 PM
Kamke Trent G (1365739) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2025 4:55 PM
LeMaitre Vascular (1158895) Issuer
O'Connor John James (1382475) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2025 4:36 PM
LeMaitre George W (1365737) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2025 4:05 PM
LeMaitre George W (1365737) Filed by
LeMaitre Vascular (1158895) Subject
Form SCHEDULE 13G/A
11/07/2025 5:59 AM
LeMaitre Vascular (1158895) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2025 8:00 PM
LeMaitre Vascular (1158895) Filer
Form 8-K/A
09/09/2025 3:40 PM
LeMaitre George W (1365737) Reporting
LeMaitre Vascular (1158895) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

LeMaitre Vascular SEC Filings - Frequently Asked Questions

LeMaitre Vascular (LMAT) has submitted 658+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

LeMaitre Vascular's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on LeMaitre Vascular's financial statements page.

The most recent filing was a Form 4 submitted on June 5, 2026. This was an insider ownership change filed by 4 - LEMAITRE VASCULAR INC (0001158895) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:LMAT) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners